Highline Wealth Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.92K Buy
14
+7
+100% +$1.84K ﹤0.01% 920
2026
Q1
$1.87K Hold
7
﹤0.01% 1078
2025
Q4
$1.76K Hold
7
﹤0.01% 863
2025
Q3
$2.01K Hold
7
﹤0.01% 849
2025
Q2
$1.84K Hold
7
﹤0.01% 650
2025
Q1
$1.63K Buy
+7
New +$1.7K ﹤0.01% 666

Other funds holding LH

Highline Wealth Partners's LH Position: Q2 2026 in Review

Highline Wealth Partners increased its Labcorp (LH) stake by 100% in Q2 2026, buying an estimated $1.84K and bringing the position to 14 shares worth $3.92K. The position accounts for ﹤0.01% of the portfolio, ranked #920.

Highline Wealth Partners first reported a position in LH in Q1 2025 and has held it in 6 quarters since. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Highline Wealth Partners held 14 shares of Labcorp worth $3.92K as of Q2 2026.
  • Highline Wealth Partners bought 7 Labcorp shares in Q2 2026, an estimated $1.84K.
  • Labcorp made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #920 holding.
  • Highline Wealth Partners first reported a position in Labcorp in Q1 2025 and has held it in 6 quarters since.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.